首页> Blood advances> Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

导出 LinkOut

翻译打印收藏纠错

第一作者： Jay Y,Spiegel

第一单位： Department of Medicine, University of Toronto, Toronto, Canada; and.

作者： Jay Y,Spiegel ^[1] ; Caroline,McNamara ^[2] ; James A,Kennedy ^[2] ; Tony,Panzarella ^[3] ; Andrea,Arruda ^[2] ; Tracy,Stockley ^[4] ; Mahadeo,Sukhai ^[4] ; Mariam,Thomas ^[4] ; Justyna,Bartoszko ^[1] ; Jenny,Ho ^[2] ; Nancy,Siddiq ^[2] ; Dawn,Maze ^[2] ; Aaron,Schimmer ^[2] ; Andre,Schuh ^[2] ; Hassan,Sibai ^[2] ; Karen,Yee ^[2] ; Jamie,Claudio ^[2] ; Rebecca,Devlin ^[2] ; Mark D,Minden ^[2] ; Suzanne,Kamel-Reid ^[4] ; Vikas,Gupta ^[2]

作者单位： Department of Medicine, University of Toronto, Toronto, Canada; and. ^[1] Department of Medical Oncology and Hematology. ^[2] Department of Biostatistics, and. ^[3] Advanced Molecular Diagnostics Laboratory, University Health Network, Princess Margaret Cancer Centre, Toronto, Canada. ^[4]

DOI 10.1182/bloodadvances.2017009530

PMID 29296819

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览5

Blood advances

2017年1卷20期

1729-1738页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览5

点击下载本期目录封面

Blood advances

2017年1卷20期

1729-1738页

检索历史清除

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy.

Blood advances

相似文献

同项目论文

Blood advances

相关期刊

检索历史清除